Ionis Pharmaceuticals Inc’s recent filing unveils that its Officer Monia Brett P acquired Company’s shares for reported $0.26 million on Nov 12 ’24. In the deal valued at $38.89 per share,6,629 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Swayze Eric bought 1,194 shares, generating $46,422 in total proceeds.
Before that, LOSCALZO JOSEPH bought 13,508 shares. Ionis Pharmaceuticals Inc shares valued at $525,152 were divested by the Officer at a price of $38.88 per share.
BMO Capital Markets downgraded its Ionis Pharmaceuticals Inc [IONS] rating to a Market perform from a an Outperform in a research note published on August 02, 2024; the price target was decreased to $60 from $67. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who increased its forecast for the stock in late July from “a Market perform” to “an Outperform”. Bernstein revised its rating on June 14, 2024. It rated IONS as “a Mkt perform” which previously was an “an Underperform”.
Price Performance Review of IONS
On Tuesday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -2.85% to $37.77. Over the last five days, the stock has lost -2.65%. Ionis Pharmaceuticals Inc shares have fallen nearly -25.34% since the year began. Nevertheless, the stocks have fallen -18.53% over the past one year. While a 52-week high of $54.44 was reached on 01/12/24, a 52-week low of $35.95 was recorded on 05/31/24. SMA at 50 days reached $40.28, while 200 days put it at $43.42.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 37.32, which if violated will result in even more drops to 36.88. On the upside, there is a resistance level at 38.49. A further resistance level may holdings at 39.22. The Relative Strength Index (RSI) on the 14-day chart is 40.54, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.32, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.65%. Stochastics %K at 42.16% indicates the stock is a holding.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2024-10-31, growing by 0.21 million shares to a total of 10.74 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 10.53 million shares. There was a rise of 1.92%, which implies that there is a positive sentiment for the stock.
